Focus of the two sessions: encourage domestic medical devices and other biological products to replace imports

Medical devices play an important role in the pharmaceutical industry. Not only is the market scale huge, it has exceeded 500 billion yuan in 2018, but also the growth rate is fast. According to the data of the China Medical Device Industry Development report, among the eight sub-industries of the pharmaceutical industry counted by the Ministry of Industry and Information Technology from 2013 to 2016, the annual growth rate of the medical device industry has been higher than the average. With the development of China's medical and health undertakings, the medical device industry still has a lot of room for development.

However, the analytical instrument industry is the same, and the medical device industry is also facing the problem that although the domestic market is huge, the high-end market has been monopolized by imported products for a long time. Under the background that the country vigorously promotes scientific and technological innovation and strives to solve the risk of key core technologies being "stuck", medical devices, as an industry that is also controlled by people, also need to take active measures to develop domestic technologies with independent intellectual property rights.

At the two sessions this year, two NPC deputies put forward suggestions on the development of medical devices.

Li Yan representative: encourage biological product research and development and production enterprises to carry out domestic substitution.

Li Yan is the president of Qilu Pharmaceutical Group. As a leader in the domestic biomedical industry, the proposal that Li Yan is going to submit this year's two sessions is about insisting on innovation and vigorously promoting the development of the biomedical industry. She believes that there are two main factors restricting the further strengthening of China's biomedicine: original innovation and key equipment.

In order to change the current situation that imported products in the domestic pharmaceutical industry chain occupy a dominant position in the high-end instruments, equipment, consumables and other markets, Li Yan suggested that biological product research and development and production enterprises should be encouraged to carry out domestic substitution, change the unhealthy atmosphere of domestic market preference for imported products, and give priority to domestic equipment when the quality of domestic products is comparable to that of imported products. At the same time, at the national level, through policies and regulations to support the use of imported materials and equipment in the research and marketing products for domestic material replacement.

Zhou Yunjie Representative: Broaden the application of domestic medical devices.

As the president of Haier Group, Zhou Yunjie also has a clear understanding of the weakness of domestic medical devices in the market. He believes that the reason for this problem is that, compared with imported brands with profound technology and experience accumulation and stable product quality, the technical level of domestic brands is relatively low, and the products are mainly ordinary and commonly used equipment. for a long time, small medical equipment service market has not been able to get enough trust from hospitals and doctors.

Zhou Yunjie also proposed to achieve "domestic substitution" in the field of high-end medical devices ". Therefore, this year its proposal for the pharmaceutical industry is "Recommendations on Further Broadening the Application Scenarios of Domestic Medical Devices". In the proposal, Zhou Yunjie suggested that the state should accelerate the implementation of relevant special plans, expand the application and promotion of domestic medical devices, further enhance the awareness and recognition of domestic medical devices, and promote the realization of import substitution of domestic excellent medical devices. At the same time, the state has increased capital investment to further support the research and development and technological upgrading of domestic medical devices.

The medical device industry is a track with great development potential in the pharmaceutical industry. The overall technical level of medical devices in my country still has a big gap compared with foreign countries. In the middle-end market, domestic enterprises already have the level of competition with imported products in some technologies, but in the high-end market with high technical barriers, the competitiveness of domestic enterprises is still very weak. There is still a long way to go to realize the domestic replacement of medical equipment, which requires more support from the state.